Intel, Nvidia, Eli Lilly rise premarket; BP, Novo Nordisk fall
) stock rose 0.2% after the online retail giant announced a new $79 Echo Spot alarm clock with a revamped design and improved audio quality.) stock rose 0.1% after it announced its chief scientific officer Mikael Dolsten would step down after a more than 15-year career at the drugmaker.) stock fell 1.8% after the publication of a data analysis showing Eli Lilly's treatment Mounjaro leads to faster and greater weight loss than Novo’s popular obesity drug Wegovy.) stock fell 0.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approvalIf approved, Eli Lilly's donanemab would become the second Alzheimer's drug of its kind to enter the market after Leqembi from Biogen and Eisai.
Read more »
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approvalIf approved, Eli Lilly’s donanemab would become the second Alzheimer’s drug of its kind to enter the market after Leqembi from Biogen and Eisai.
Read more »
FDA advisors recommend Eli Lilly Alzheimer’s drug that slows diseaseEli Lilly's new Alzheimer's drug, donanemab, received approval from an advisory panel for the FDA. The full agency is expected to approve the drug by spring.
Read more »
Alzheimer’s drug from Eli Lilly wins backing of FDA committeeAn advisory committee to the Food and Drug Administration found the drug was safe and effective at slowing the progression of the disease, setting the stage for the agency to approve it.
Read more »
Apple, Coinbase, Yext fall premarket; GM, Eli Lilly riseApple, Coinbase, Yext fall premarket; GM, Eli Lilly rise
Read more »
Stocks making the biggest moves premarket: Eli Lilly, General Motors, ShopifyThese are the stocks posting the largest moves in premarket trading.
Read more »